The gap between trailing and forward P/E implies the market expects earnings to rebound materially, and the 21.1x EV/EBITDA trailing versus 14.4x forward reinforces that view. Relative to peers such as MDLZ at 35.4x and MKC at 17.1x, HSY carries a premium that appears to reflect its brand durability and defensive consumer profile rather than near-term growth. Investors should monitor whether forward estimates hold, since a premium multiple leaves limited room for disappointment if margin recovery stalls.

Net margin expanded in parallel to 17.7%, and gross margin recovered to 46.1%, which may indicate that cocoa cost pressure has eased for now. The sharp reversal in a short window, however, suggests the trailing figures are sensitive to timing and commodity hedging effects rather than a smooth underlying trend. Treating the 2026Q3 operating margin as a sustainable run-rate would be premature without confirmation across additional periods.

The ROIC trajectory reflects both margin expansion and a stabilizing asset base, with ROE climbing from 1.4% to 12.3% over the same window. Because ROE is amplified by leverage at a 1.05 debt-to-equity ratio, the gap between ROE and ROIC warrants attention as a signal of how much of the return is financial rather than operational. The recovery appears real in direction but the level still lags the group, suggesting the capital base is not yet compounding efficiently.

Part of the improvement in debt-to-equity from 1.44 to 1.05 reflects a growing equity denominator as retained earnings accumulated, rather than debt reduction alone. Total debt declined from a peak near $6.3B to roughly $5.1B, which suggests meaningful repayment capacity. Investors should note that the leverage metrics are highly sensitive to the EBITDA denominator, so a reversal in margins would quickly reverse the coverage improvement.